NCT04261777 2025-06-03
Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients
Saving Patients' Lives Medical B.V.
Phase 3 Terminated
Clinical Trials
4 trialsNCT00188695 2022-10-07
Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide
University Health Network, Toronto
Phase 1/2 Completed
NCT00147238 2012-08-07
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00622973 2011-10-12
USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases
Insel Gruppe AG, University Hospital Bern
Phase 3 Completed